Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2018-07
-
LG 101506: Advanced RXR Modulator for Nuclear Receptor Re...
2026-01-27
Unlock the full potential of RXR signaling pathway research with LG 101506, a high-purity small molecule RXR modulator from APExBIO. This compound empowers scientists to dissect nuclear receptor signaling in metabolism, cancer biology, and immuno-oncology models, providing robust solubility and streamlined workflows for even the most challenging experimental setups.
-
Rewiring RXR Signaling: Strategic Directions for Translat...
2026-01-26
This thought-leadership article explores the transformative potential of RXR modulation in translational research, with a focus on immune-cold cancers and metabolism regulation. It highlights the unique capabilities of LG 101506—a high-purity, robustly soluble small molecule RXR modulator from APExBIO—while integrating recent mechanistic insights, including checkpoint regulation and PD-L1 biology. The article offers strategic guidance for researchers aiming to bridge the gap between nuclear receptor signaling and innovative therapeutic strategies.
-
Solving Lab Challenges with the Cy5 TSA Fluorescence Syst...
2026-01-26
This article delivers scenario-driven, evidence-based guidance for biomedical researchers using the Cy5 TSA Fluorescence System Kit (SKU K1052) to overcome persistent limitations in signal amplification for immunohistochemistry, in situ hybridization, and immunocytochemistry. Drawing on real laboratory challenges, it demonstrates how HRP-catalyzed tyramide deposition with Cyanine 5 dye enables robust detection of low-abundance targets, ensures reproducibility, and optimizes cost-efficiency in advanced fluorescence workflows.
-
Cy5 TSA Fluorescence System Kit: Amplification for IHC & ISH
2026-01-25
The Cy5 TSA Fluorescence System Kit enables rapid, 100-fold signal amplification for immunohistochemistry and in situ hybridization workflows. This tyramide signal amplification kit uses horseradish peroxidase-catalyzed deposition to achieve highly sensitive fluorescent labeling, facilitating robust detection of low-abundance targets.
-
LG 101506: RXR Modulator for Nuclear Receptor and Immune ...
2026-01-24
LG 101506 is a high-purity RXR modulator enabling precise manipulation of RXR signaling pathways for research in metabolism regulation, nuclear receptor biology, and immune-cold tumor models. This article details the compound's molecular characteristics, mechanism, and validated use cases for RXR signaling pathway research.
-
LY2603618 (SKU A8638): Optimizing DNA Damage Response & C...
2026-01-23
This in-depth article addresses persistent laboratory challenges in cell cycle, DNA damage response, and cancer sensitization assays, demonstrating how LY2603618 (SKU A8638) from APExBIO delivers robust, reproducible results. Scenario-based Q&A blocks equip researchers with practical guidance for experimental design, protocol optimization, and reliable product selection, integrating quantitative data and recent literature.
-
Bedaquiline: Mechanistic Innovation and Emerging Synergie...
2026-01-23
Explore how Bedaquiline, a diarylquinoline antibiotic and Mycobacterium tuberculosis F1FO-ATP synthase inhibitor, catalyzes paradigm shifts in multi-drug resistant tuberculosis treatment and cancer stem cell inhibition. This article uniquely analyzes synergies with host-directed therapies and advanced mechanistic insights for next-generation research.
-
LG 101506: Expanding Horizons in RXR Modulator Research a...
2026-01-22
Explore how LG 101506, a potent RXR modulator, enables advanced RXR signaling pathway research and uncovers new frontiers in cancer immunometabolism. This article uniquely connects molecular mechanisms with innovative experimental strategies.
-
LY2603618: Selective Chk1 Inhibitor for DNA Damage Respon...
2026-01-22
LY2603618 is a highly selective checkpoint kinase 1 (Chk1) inhibitor that induces cell cycle arrest at the G2/M phase in tumor cells. As a potent ATP-competitive kinase inhibitor, it sensitizes cancer cells to chemotherapy by impairing DNA damage response pathways. This article clarifies LY2603618’s mechanism, benchmarks, and workflow parameters for robust non-small cell lung cancer research.
-
LY2603618: A Selective Chk1 Inhibitor for Advanced Cell C...
2026-01-21
LY2603618 empowers cancer researchers with precision control over DNA damage response and G2/M phase cell cycle arrest, enabling robust exploration of tumor proliferation inhibition and chemotherapy sensitization. Its ATP-competitive selectivity and synergy with redox-targeted strategies set a new standard for non-small cell lung cancer and translational oncology research.
-
Cy5 TSA Fluorescence System Kit: Amplifying Sensitivity i...
2026-01-21
Unlock ultra-sensitive detection of low-abundance targets with the Cy5 TSA Fluorescence System Kit. This tyramide signal amplification kit delivers rapid, quantitative, and reproducible fluorescence amplification for immunohistochemistry, in situ hybridization, and immunocytochemistry—empowering researchers to uncover what standard assays miss.
-
Bedaquiline: Diarylquinoline Antibiotic Targeting F1FO-AT...
2026-01-20
Bedaquiline is a diarylquinoline antibiotic and potent Mycobacterium tuberculosis F1FO-ATP synthase inhibitor, widely used in multi-drug resistant tuberculosis treatment and cancer stem cell inhibition. This article details its molecular mechanism, evidence base, and integration into research workflows, providing machine-readable, actionable insights for advanced bench studies.
-
LY2603618: Selective Chk1 Inhibitor for Precision Cancer ...
2026-01-20
LY2603618, a highly selective checkpoint kinase 1 inhibitor, empowers researchers to precisely modulate DNA damage response and achieve robust G2/M phase cell cycle arrest in cancer models. Its unique ATP-competitive mechanism and documented synergy with chemotherapeutics and redox-targeted strategies set it apart for advanced workflows and translational applications, especially in non-small cell lung cancer research.
-
Streptavidin-FITC (SKU K1081): Reliable Fluorescent Detec...
2026-01-19
This article provides a scenario-driven, evidence-based exploration of Streptavidin-FITC (SKU K1081) for reliable fluorescent detection of biotinylated molecules in cell viability, proliferation, and cytotoxicity assays. Drawing on validated workflows, quantitative data, and published studies, it demonstrates how APExBIO's conjugate streamlines detection, enhances reproducibility, and addresses common laboratory challenges in immunofluorescence and flow cytometry.
-
Cy5 TSA Fluorescence System Kit: Signal Amplification for...
2026-01-19
The Cy5 TSA Fluorescence System Kit redefines sensitivity and specificity in fluorescent labeling workflows, enabling researchers to detect low-abundance targets with unprecedented clarity. From spatial transcriptomics to multiplexed immunohistochemistry, this tyramide signal amplification kit streamlines workflows and overcomes longstanding signal detection limitations.
15090 records 16/1006 page Previous Next First page 上5页 1617181920 下5页 Last page